American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Broadcom
AVGO
|
+$701M |
| 2 |
Mastercard
MA
|
+$306M |
| 3 |
Estee Lauder
EL
|
+$248M |
| 4 |
IQVIA
IQV
|
+$178M |
| 5 |
Arista Networks
ANET
|
+$163M |
Top Sells
| 1 |
Visa
V
|
+$560M |
| 2 |
Advanced Micro Devices
AMD
|
+$524M |
| 3 |
Apple
AAPL
|
+$439M |
| 4 |
NVIDIA
NVDA
|
+$318M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$261M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Financials | 13.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Healthcare | 10.02% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Fate Therapeutics
FATE
$111M
| $326K | ﹤0.01% |
197,704
+12,295
| +7% | +$20.3K |
|
2602
Progyny
PGNY
$1.94B
| $324K | ﹤0.01% |
18,783
-34,508
| -65% | -$595K |
|
2603
ReposiTrak
TRAK
$311M
| $323K | ﹤0.01% |
14,611
+1,581
| +12% | +$35K |
|
2604
Altimmune
ALT
$321M
| $323K | ﹤0.01% |
44,742
+11,788
| +36% | +$85K |
|
2605
STAAR Surgical
STAA
$1.37B
| $322K | ﹤0.01% |
13,256
+5,457
| +70% | +$133K |
|
2606
Trevi Therapeutics
TRVI
$1B
| $322K | ﹤0.01% |
78,143
+24,153
| +45% | +$99.5K |
|
|
BDN
2607
Brandywine Realty Trust
BDN
$789M
| $321K | ﹤0.01% |
57,334
| – | – |
|
2608
American Superconductor
AMSC
$2.54B
| $320K | ﹤0.01% |
+13,008
| New | +$320K |
|
|
ATYR
2609
aTyr Pharma
ATYR
$591M
| $319K | ﹤0.01% |
88,112
+26,516
| +43% | +$96K |
|
2610
NextDecade
NEXT
$1.79B
| $319K | ﹤0.01% |
+41,322
| New | +$319K |
|
2611
Lufax Holding
LU
$2.61B
| $318K | ﹤0.01% |
133,255
+45
| +0% | +$108 |
|
|
AIV
2612
Aimco
AIV
$1.07B
| $318K | ﹤0.01% |
+35,023
| New | +$318K |
|
2613
Unity
U
$18.4B
| $318K | ﹤0.01% |
+14,144
| New | +$318K |
|
2614
Forward Air
FWRD
$904M
| $317K | ﹤0.01% |
+9,838
| New | +$317K |
|
2615
Rezolute
RZLT
$669M
| $316K | ﹤0.01% |
64,591
+24,742
| +62% | +$121K |
|
2616
Organogenesis Holdings
ORGO
$625M
| $316K | ﹤0.01% |
98,892
+9,311
| +10% | +$29.8K |
|
2617
Westrock Coffee
WEST
$508M
| $316K | ﹤0.01% |
49,214
-1,595
| -3% | -$10.2K |
|
2618
SEACOR Marine Holdings
SMHI
$180M
| $310K | ﹤0.01% |
47,181
+4,616
| +11% | +$30.3K |
|
2619
Arteris
AIP
$373M
| $309K | ﹤0.01% |
30,357
+1,731
| +6% | +$17.6K |
|
2620
Tyra Biosciences
TYRA
$667M
| $308K | ﹤0.01% |
22,142
-20,857
| -49% | -$290K |
|
2621
Omega Flex
OFLX
$340M
| $308K | ﹤0.01% |
7,327
+933
| +15% | +$39.2K |
|
2622
BK Technologies
BKTI
$267M
| $306K | ﹤0.01% |
+8,930
| New | +$306K |
|
2623
Flutter Entertainment
FLUT
$49.4B
| $303K | ﹤0.01% |
+1,171
| New | +$303K |
|
2624
Brown-Forman Class A
BF.A
$13.2B
| $299K | ﹤0.01% |
7,946
+322
| +4% | +$12.1K |
|
2625
InMode
INMD
$937M
| $299K | ﹤0.01% |
+17,907
| New | +$299K |
|